- Home
- AGMB vs DDL Comparison
AGMB vs DDL Comparison
Compare AGMB & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGMB | DDL |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | Belgium | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.2M | 494.2M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AGMB | DDL |
|---|---|---|
| Price | $9.23 | $1.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $37.67 | $3.28 |
| AVG Volume (30 Days) | 114.4K | ★ 224.1K |
| Earning Date | 11-14-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $9.66 |
| P/E Ratio | ★ N/A | $16.08 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.92 | $1.65 |
| 52 Week High | $17.82 | $3.41 |
Technical Indicators
Market Signals| Indicator | AGMB | DDL |
|---|---|---|
| Relative Strength Index (RSI) | 42.95 | 32.92 |
| Support Level | $8.88 | $1.86 |
| Resistance Level | $9.65 | $2.65 |
| Average True Range (ATR) | 0.63 | 0.07 |
| MACD | 0.16 | -0.01 |
| Stochastic Oscillator | 73.99 | 1.64 |
Price Performance
Historical ComparisonAbout AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd are a foremost fresh grocery e-commerce company in mainland China with sustainable growth. It directly provide users and households with fresh groceries, prepared food and other food products through delivering a convenient and excellent shopping experience supported by an extensive self-operated frontline fulfillment grid. The Group operates and manages its business as a single segment. The Group generates substantially all of its revenues from customers in the PRC.